Giuliano A.E. Edge S.B. Hortobagyi G.N.

Eighth edition of the AJCC cancer staging manual: breast cancer.

Ann Surg Oncol. 2018; 25: 1783-1785View in Article Google ScholarMariotto A.B. Etzioni R. Hurlbert M. et al.

Estimation of the number of women living with metastatic breast cancer in the united states.

Cancer Epidemiol Biomarkers Prev. 2017; 26: 809-815View in Article Google ScholarAmerican Cancer Society

Breast Cancer Facts & Figures 2019-2020.

https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/breast-cancer-facts-and-figures/breast-cancer-facts-and-figures-2019-2020.pdf

Date accessed: May 12, 2022

View in Article Google ScholarThomas A. Khan S.A. Chrischilles E.A. et al.

Initial surgery and survival in stage IV Breast cancer in the united states, 1988-2011.

JAMA Surg. 2016; 151: 424-431View in Article Google ScholarTeshome M.

Role of operative management in stage IV breast cancer.

Surg Clin North Am. 2018; 98: 859-868https://doi.org/10.1016/j.suc.2018.03.012View in Article Google ScholarFlanigan R.C. Salmon S.E. Blumenstein B.A. et al.

Nephrectomy followed by interferon Alfa-2b compared with interferon Alfa-2b alone for metastatic renal-cell cancer.

N Engl J Med. 2001; 345: 1655-1659View in Article Google ScholarMickisch G.H.J. Garin A. van Poppel H. et al.

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial.

Lancet. 2001; 358: 966-970View in Article Google ScholarNational Comprehensive Cancer Network

NCCN clinical practice guidelines in oncology: breast cancer, Version 1.2022.

(Available at:)https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1419View in Article Google ScholarFreedman R.A. Keating N.L. Lin N.U. et al.

Breast cancer-specific survival by age: worse outcomes for the oldest patients.

Cancer. 2018; 124: 2184-2191View in Article Google ScholarChitapanarux I. Sripan P. Somwangprasert A. et al.

Stage-specific survival rate of breast cancer patients in northern thailand in accordance with two different staging systems.

Asian Pac J Cancer Prev. 2019; 20: 2699-2706View in Article Google ScholarRashid O.M. Takabe K.

Does removal of the primary tumor in metastatic breast cancer improve survival?.

J Womens Health (Larchmt). 2014; 23: 184-188View in Article Google ScholarFolkman J.

New perspectives in clinical oncology from angiogenesis research.

Eur J Cancer. 1996; 32: 2534-2539View in Article Google ScholarFisher E.R. Fisher B.

Experimental studies of factors influencing the development of hepatic metastases: XIII. Effect of hepatic trauma in parabiotic pairs.

Cancer Res. 1963; 23: 896-900View in Article Google ScholarAl-Sahaf O. Wang J.H. Browne T.J. et al.

Surgical injury enhances the expression of genes that mediate breast cancer metastasis to the lung.

Ann Surg. 2010; 252: 1037-1043View in Article Google ScholarFerrand F. Malka D. Bourredjem A. et al.

Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: Results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601.

Eur J Cancer. 2013; 49: 90-97View in Article Google ScholarKhan S.A. Stewart A.K. Morrow M.

Does aggressive local therapy improve survival in metastatic breast cancer? Surgery.

. 2002; 132 ([discussion: 626-7]): 620-626View in Article Google ScholarRapiti E. Verkooijen H.M. Vlastos G. et al.

Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis.

J Clin Oncol. 2006; 24: 2743-2749View in Article Google ScholarGnerlich J. Jeffe D.B. Deshpande A.D. et al.

Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988–2003 SEER data.

Ann Surg Oncol. 2007; 14: 2187-2194View in Article Google ScholarBabiera G.V. Rao R. Feng L. et al.

Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor.

Ann Surg Oncol. 2006; 13: 776-782View in Article Google ScholarLang J.E. Tereffe W. Mitchell M.P. et al.

Primary Tumor extirpation in breast cancer patients who present with stage IV disease is associated with improved survival.

Ann Surg Oncol. 2013; 20: 1893-1899View in Article Google ScholarFields R.C. Jeffe D.B. Trinkaus K. et al.

Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site of metastasis.

Ann Surg Oncol. 2007; 14: 3345-3351View in Article Google ScholarBlanchard D.K. Shetty P.B. Hilsenbeck S.G. et al.

Association of surgery with improved survival in stage IV breast cancer patients.

Ann Surg. 2008; 247: 732-738View in Article Google ScholarBafford A.C. Burstein H.J. Barkley C.R. et al.

Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival.

Breast Cancer Res Treat. 2009; 115: 7-12View in Article Google ScholarRuiterkamp J. Ernst M.F. van de Poll-Franse L.V. et al.

Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis.

Eur J Surg Oncol (EJSO). 2009; 35: 1146-1151View in Article Google ScholarVohra N.A. Brinkley J. Kachare S. et al.

Primary tumor resection in metastatic breast cancer: a propensity-matched analysis, 1988-2011 SEER data base.

Breast J. 2018; 24: 549-554View in Article Google ScholarStahl K. Wong W. Dodge D. et al.

Benefits of surgical treatment of stage IV breast cancer for patients with known hormone receptor and HER2 status.

Ann Surg Oncol. 2021; 28: 2646-2658View in Article Google ScholarDominici L. Najita J. Hughes M. et al.

Surgery of the primary tumor does not improve survival in stage IV breast cancer.

Breast Cancer Res Treat. 2011; 129: 459-465View in Article Google ScholarCady B. Nathan N.R. Michaelson J.S. et al.

Matched pair analyses of stage IV breast cancer with or without resection of primary breast site.

Ann Surg Oncol. 2008; 15: 3384-3395View in Article Google ScholarKing T. Lyman J. Gonen M. et al.

Abstract P2-18-09: TBCRC 013: a prospective analysis of the role of surgery in stage IV breast cancer.

Cancer Res. 2013; 73 (18-09-P2-18-09): P2View in Article Google ScholarKing T.A. Lyman J. Gonen M. et al.

A prospective analysis of surgery and survival in stage IV breast cancer (TBCRC 013).

J Clin Oncol. 2016; 34: 1006View in Article Google ScholarBadwe R. Hawaldar R. Nair N. et al.

Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial.

Lancet Oncol. 2015; 16: 1380-1388View in Article Google ScholarSoran A. Ozmen V. Ozbas S. et al.

Randomized trial comparing resection of primary tumor with no surgery in stage IV breast cancer at presentation: protocol MF07-01.

Ann Surg Oncol. 2018; 25: 3141-3149View in Article Google ScholarFitzal F. Bjelic-Radisic V. Knauer M. et al.

Impact of breast surgery in primary metastasized breast cancer: outcomes of the prospective randomized phase III ABCSG-28 POSYTIVE trial.

Ann Surg. 2019; 269: 1163-1169View in Article Google ScholarKhan S.A. Zhao F. Goldstein L.J. et al.

Early local therapy for the primary site in de novo stage IV breast cancer: results of a randomized clinical trial (EA2108).

J Clin Oncol. 2022; 40: 978-987View in Article Google ScholarKhan S.A. Zhao F. Solin L.J. et al.

A randomized phase III trial of systemic therapy plus early local therapy versus systemic therapy alone in women with de novo stage IV breast cancer: a trial of the ECOG-ACRIN Research Group (E2108).

J Clin Oncol. 2020; 38: LBA2View in Article Google ScholarShien T. Mizutani T. Tanaka K. et al.

A randomized controlled trial comparing primary tumor resection plus systemic therapy with systemic therapy alone in metastatic breast cancer (JCOG1017 PRIM-BC).

J Clin Oncol. 2017; 35: TPS588View in Article Google ScholarHotton J. Lusque A. Leufflen L. et al.

Early locoregional breast surgery and survival in de novo metastatic breast cancer in the multicenter national ESME cohort.

Ann Surg. 2021; https://doi.org/10.1097/sla.0000000000004767View in Article Google ScholarBarinoff J. Schmidt M. Schneeweiss A. et al.

Primary metastatic breast cancer in the era of targeted therapy – Prognostic impact and the role of breast tumour surgery.

Eur J Cancer. 2017; 83: 116-124View in Article Google ScholarBishop A.J. Ensor J. Moulder S.L. et al.

Prognosis for patients with metastatic breast cancer who achieve a no-evidence-of-disease status after systemic or local therapy.

Cancer. 2015; 121: 4324-4332View in Article Google ScholarSingletary S.E. Walsh G. Vauthey J.-N. et al.

A Role for curative surgery in the treatment of selected patients with metastatic breast cancer.

Oncologist. 2003; 8: 241-251View in Article Google ScholarFan J. Chen D. Du H. et al.

Prognostic factors for resection of isolated pulmonary metastases in breast cancer patients: a systematic review and meta-analysis.

J Thorac Dis. 2015; 7: 1441-1451View in Article Google ScholarChmura S.J. Winter K.A. Al-Hallaq H.A. et al.

NRG-BR002: a phase IIR/III trial of standard of care therapy with or without stereotactic body radiotherapy (SBRT) and/or surgical ablation for newly oligometastatic breast cancer (NCT02364557).

J Clin Oncol. 2019; 37: TPS1117View in Article Google ScholarWingo P.A. Jamison P.M. Young J.L. et al.

Population-based statistics for women diagnosed with inflammatory breast cancer (United States).

Cancer Causes & Control. 2004; 15: 321-328View in Article Google ScholarFouad T.M. Kogawa T. Liu D.D. et al.

Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis.

Breast Cancer Res Treat. 2015; 152: 407-416View in Article Google ScholarAkay C.L. Ueno N.T. Chisholm G.B. et al.

Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancer.

Cancer. 2014; 120: 1319-1328View in Article Google ScholarWarren L.E. Guo H. Regan M.M. et al.

Inflammatory breast cancer: patterns of failure and the case for aggressive locoregional management.

Ann Surg Oncol. 2015; 22: 2483-2491View in Article Google ScholarTakiar V. Akay C.L. Stauder M.C. et al.

Predictors of durable no evidence of disease status in de novo metastatic inflammatory breast cancer patients treated with neoadjuvant chemotherapy and post-mastectomy radiation.

Springerplus. 2014; 3: 166View in Article Google Scholar